Erythema Migrans - 13/08/11
Doi : 10.1016/j.idc.2007.12.012
Patricia Dandache, MD, Robert B. Nadelman, MD ⁎ 
Division of Infectious Diseases, Department of Medicine, New York Medical College, Munger Pavilion 245, Valhalla, NY 10595, USA
Corresponding author.Abstract |
Erythema migrans (EM) is the most common objective manifestation of Lyme disease, accounting for about 90% of cases. Establishing the diagnosis of EM is important because appropriate treatment with oral antibiotics at an early stage of infection with Borrelia burgdorferi results in excellent outcomes. This article includes a discussion of the epidemiology of EM and its clinical, differential, and laboratory diagnosis. The treatment of EM and the prevention of Lyme disease are also discussed.
Le texte complet de cet article est disponible en PDF.Plan
© 2008
Elsevier Inc. Tous droits réservés.
Vol 22 - N° 2
P. 235-260 - juin 2008 Retour au numéro
Article précédent
- Biology of Infection with Borrelia burgdorferi
- Kit Tilly, Patricia A. Rosa, Philip E. Stewart
- Nervous System Lyme Disease
- John J. Halperin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?